Chronic Obstructive Pulmonary Disease
- 1 January 1996
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 52 (2), 55-61
- https://doi.org/10.2165/00003495-199600522-00012
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEuropean Respiratory Journal, 1995
- Dornase AlfaDrugs, 1994
- Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.1994
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Slowing the Deterioration of Asthma and Chronic Obstructive Pulmonary Disease Observed during Bronchodilator Therapy by Adding Inhaled Corticosteroids: A 4-Year Prospective StudyAnnals of Internal Medicine, 1993
- Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.BMJ, 1991
- Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.Proceedings of the National Academy of Sciences, 1990
- Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party.1981
- Continuous or Nocturnal Oxygen Therapy in Hypoxemic Chronic Obstructive Lung DiseaseAnnals of Internal Medicine, 1980
- The natural history of chronic airflow obstruction.BMJ, 1977